Holen Sie sich die Stockscreener-App
24.32
1.84%
0.44
Handel nachbörslich:
24.34
0.02
+0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline - AOL.com
Form 4 Pfizer For: 1 July By Investing.com - Investing.com Canada
Pfizer Inc. focuses on long-term therapies as investors watch the stock - AD HOC NEWS
Can Pfizer (NYSE:PFE) Advance Its Next-Generation Oncology Pipeline? - Kalkine Media
Pfizer Expands Migraine Strategy With New Rimegepant Redosing Study - TipRanks
Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy? - Yahoo Finance
June Social Media Round-Up—2025 Impact Report, ADA 2026, and More - Pfizer
Is Pfizer (PFE) Stock Undervalued Despite Mixed Oncology Progress? - Yahoo Finance
Nike Appoints Pfizer CFO as New Finance Chief Amid Industry Experience Questions - marketscreener.com
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch
Pfizer (NYSE:PFE) yield tops 7% after stock falls on China GLP-1 news - TechStock²
Form 4 Pfizer For: 30 June By Investing.com - Investing.com Canada
Pfizer-BioNTech COVID-19 Vaccine from Pfizer Inc.mRNA shot anchoring US immunization plans - AD HOC NEWS
Why Pfizer Could Prove to Be an Underrated GLP-1 Stock - The Globe and Mail
Pfizer Inc (NYSE:PFE) Reshapes Healthcare Pipeline Through Dealmaking - Kalkine Media
Pfizer opens the week with a clear earnings calendar, shares on NYSE in focus - AD HOC NEWS
Parasite Cleanse Market to See Booming Growth 2026-2033 | Bayer AG, Pfizer Inc., Merck & Co., Inc. - openPR.com
Big Pharma Has a Case of Merger Mania - The Motley Fool
The Paxlovid tablets from Pfizer Inc.antiviral course that fits into daily routine - AD HOC NEWS
Why Is Pfizer (NYSE:PFE) Catching Value Stock Attention? - Kalkine Media
PFE Stock Quote Price and Forecast - CNN
Will FDA’s New IBRANCE (palbociclib) Maintenance Approval Reshape Pfizer’s (PFE) Oncology Narrative? - simplywall.st
Pfizer, Innovent GLP-1 drugs clear China insurance hurdle - Reuters
Is Pfizer Inc. (PFE) A Good Stock To Buy Now? - Insider Monkey
Pfizer muted in pharma sector comparison, shares trail S&P 500 peers - AD HOC NEWS
Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review - Yahoo Finance
Pfizer’s CFO Just Left and a Key Drug Trial Missed. Here’s What That Means for PFE Stock in 2026 - TIKR.com
China surpassing Europe in Drug Innovation and Development, Pfizer Inc. (PFE) Executive says - Insider Monkey
Pfizer (NYSE:PFE) yield math back in focus after cancer drug miss, shares recover Friday - TechStock²
Pfizer (PFE) Could Be 13% Undervalued On Mixed Oncology News And CFO Change - simplywall.st
Pfizer Inc. - Encyclopedia Britannica
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now - The Motley Fool
Is Pfizer (NYSE:PFE) Building A Stronger Cancer Portfolio? - Kalkine Media
Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly Dividends - Yahoo Finance
Pfizer (PFE) Wins EU Approval For Keytruda And Padcev In Bladder Cancer - simplywall.st
Pfizer Beats Ex-Worker's Whistleblower Retaliation Suit - Law360
Prevnar 20 from Pfizer Inc.broader pneumococcal cover in one syringe - Ad-hoc-news.de
Pfizer Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Price to earnings forward of Pfizer Inc. – BCS:PFECL - TradingView
Why Did Pfizer (NYSE:PFE) Gain Attention After FDA Approval? - Kalkine Media
Pfizer: Why Being Bullish Makes Sense Despite The Patent Cliff (NYSE:PFE) - Seeking Alpha
Nike Names Pfizer’s Denton as Next CFO - WSJ
Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer? - Yahoo Finance
A Big Pharma Executive Is Jumping to Nike—and Critics Are Already Questioning the Move - inc.com
Pfizer Discontinues Vizimpro In US Amid Oncologist Preference Shift - insights.citeline.com
Vitiligo Market to Witness Transformational Growth Opportunities by 2034 – DelveInsight | Pfizer, Clinuvel, Inc., Clinuvel Pharma, Bioniz Therapeutics, TAGCyx Biotech - Barchart.com
A Prostate Cancer Survivor Shares the Importance of Early Detection—and Why Knowing Your History, Monitoring PSA and Talking to Your Doctor Matters - Pfizer
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Dividend Roundup: Pfizer, AT&T, Comcast, Sysco, and more - Seeking Alpha
Pfizer (PFE) Wins New IBRANCE Use As Lung Cancer Trial Tests Its Pipeline - simplywall.st
Pfizer reaffirmed 2026 guidance after CFO exit, shares trade near recent lows - AD HOC NEWS
Price to sales forward of Pfizer, Inc. – NYSE:PFE - TradingView
Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh Actuals & Estimates (BMFBOVESPA:PFIZ34) - TradingView
Pfizer stock under pressure near yearly lows despite launch of new obesity study programs - Traders Union
Price to earnings forward of Pfizer Inc. – TRADEGATE:PFE - TradingView
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? - The Motley Fool
Pfizer Inc. Actuals & Estimates (BVC:PFE) - TradingView
Pfizer Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Antibody-Drug Conjugates: Not Quite Worked Out Yet (PFE) - Seeking Alpha
Enterprise value to revenue forward of Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs – BCBA:PFE.B - TradingView
FDA expands Pfizer's Ibrance label for frontline maintenance in advanced breast cancer - MSN
4.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):